Experienced in Lethal Congenital Contracture Syndrome

David Andres-Gomez

Barcelona, CT, ES 
Experienced in Lethal Congenital Contracture Syndrome
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

David Andres-Gomez practices in Barcelona, Spain. Mr. Andres-Gomez is rated as an Experienced expert by MediFind in the treatment of Lethal Congenital Contracture Syndrome. His top areas of expertise are Primary Lateral Sclerosis, Myoclonus-Dystonia, Spinal Muscular Atrophy (SMA), and Lethal Congenital Contracture Syndrome.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Lethal Congenital Contracture Syndrome.

Gender
Male

Locations

Barcelona, CT, Spain
Other Locations
Bellaterra, CT, Spain
Spain
Madrid, MD 28029, Spain
La Paz, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: August 26, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 1 Less Clinical Trial

52 Total Publications

Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project.
Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project.
Journal: Journal of neuromuscular diseases
Published: July 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Andres-Gomez's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile